Jeito Capital
Status
ACTIVE
Global HQ
Paris, France
Countries of investment
- France
Investment stages
- Seed
Industries
- Health Tech
- Biotechnology
About
Jeito Capital: A global biotech fund accelerating medical innovation with a patient benefit focus and societal impact. Empowering entrepreneurs to advance healthcare breakthroughs.
Jeito Capital: A global biotech fund accelerating medical innovation with a patient benefit focus and societal impact. Empowering entrepreneurs to advance healthcare breakthroughs.
Investment Thesis
Jeito Capital focuses on financing and accelerating groundbreaking medical innovation with the aim to build market leaders in their respective therapeutic areas, ensuring accelerated patient access globally.
Manager's Experience
Bringing over two decades of investment expertise, the fund manager has successfully completed more than 25 deals across technology and healthcare sectors, primarily in North America and Europe. With a thematic investment approach that emphasizes operator-first strategies, the manager has achieved several notable exits, enhancing portfolio performance. Leveraging data-driven insights, they focus on early to growth-stage companies, identifying transformative opportunities within dynamic markets. This diverse experience equips the manager with a robust framework for navigating complex investment landscapes.
Team
Rafaèle Tordjman – Founder & CEO
Frédéric Degive – Partner
Marie-Morgane Colle – Partner
Edouard Vitry – Principal
Mikael Dolsten – Senior Advisor
Portfolio
Calliditas Therapeutics
Polares Medical
Neogene Therapeutics
Amolyt Pharma
SparingVision